P. Vandensteen et al., CONCEPTS AND PRINCIPLES OF O-LINKED GLYCOSYLATION, Critical reviews in biochemistry and molecular biology, 33(3), 1998, pp. 151-208
The biosynthesis, structures, and functions of O-glycosylation, as a c
omplex posttranslational event, is reviewed and compared for the vario
us types of O-glycans. Mucin-type O-glycosylation is initiated by tiss
ue-specific addition of a GalNAc-residue to a serine or a threonine of
the fully folded protein. This event is dependent on the primary, sec
ondary, and tertiary structure of the glycoprotein. Further elongation
and termination by specific transferases is highly regulated. We also
describe some of the physical and biological properties that O-glycos
ylation confers on the protein to which the sugars are attached. These
include providing the basis for rigid conformations and for protein s
tability. Clustering of O-glycans in Ser/Thr(/Pro)-rich domains allows
glycan determinants such as sialyl Lewis X to be presented as multiva
lent ligands, essential for functional recognition. An additional leve
l of regulation, imposed by exon shuffling and alternative splicing of
mRNA, results in the expression of proteins that differ only by the p
resence or absence of Ser/Thr(/Pro)-rich domains. These domains may se
rve as protease-resistant spacers in cell surface glycoproteins. Furth
er biological roles for O-glycosylation discussed include the role of
isolated mucin-type O-glycans in recognition events (e.g., during fert
ilization and in the immune response) and in the modulation of the act
ivity of enzymes and signaling molecules. In some cases, the O-linked
oligosaccharides are necessary for glycoprotein expression and process
ing. In contrast to the more common mucin-type O-glycosylation, some s
pecific types of O-glycosylation, such as the O-linked attachment of f
ucose and glucose, are sequon dependent. The reversible attachment of
O-linked GlcNAc to cytoplasmic and nuclear proteins is thought to play
a regulatory role in protein function. The recent development of nove
l technologies for glycan analysis promises to yield new insights in t
he factors that determine site occupancy, structure-function relations
hip, and the contribution of O-linked sugars to physiological and path
ological processes. These include diseases where one or more of the O-
glycan processing enzymes are aberrantly regulated or deficient, such
as HEMPAS and cancer.